The Economist Logo

Genetic Shock

There’s a massive debate going on in the medical world, with regards to the BRCA patent. Many claim that the two gene patents, unlawfully stifle both innovation and basic science. But given the history of patent rulings in America, that has been a fringe argument—until now. Federal district court judge Robert Sweet in New York made a ruling that, taken at face value, turns America’s approach to the patent protection of genes on its head.

To read more, click here.

Similar Posts